Sundrug Co.,Ltd. (SDGCF) Stock Price, News & Analysis

Company Overview

Sundrug Co., Ltd. is a Japan-based drugstore chain operator that manages a nationwide network of over 1,300 retail outlets. The company’s primary business centers on the sale of pharmaceuticals and related health products through its Sundrug-branded stores. In addition to traditional bricks-and-mortar locations, Sundrug has developed an e-commerce platform, allowing customers to purchase many of the same items online for home delivery or in-store pickup.

The company’s product range spans prescription and over-the-counter medications, dietary supplements, cosmetics, personal care and beauty items, baby products, foodstuffs and household essentials. Sundrug partners with both domestic and international suppliers to offer a mix of well-known brands alongside its private-label lines. These proprietary products are positioned to deliver competitive pricing while adhering to quality standards, reinforcing the company’s value proposition for cost-conscious consumers.

Serving primarily the Japanese market, Sundrug has strategically expanded its presence in urban and suburban regions to meet diverse customer needs. The company emphasizes knowledgeable in-store consultations, with trained staff guiding customers on product selection and usage. While detailed corporate leadership information is not broadly disclosed, Sundrug’s continued store expansion and online retail initiatives underscore its commitment to providing a comprehensive, one-stop shopping experience for health and wellness needs across Japan.

Key Stats

• Today's Range: $27.34 to $27.76
• 50-Day Range: $27.76 to $28.18
• 52-Week Range: $28.18 to $28.18
• Volume: N/A
• Average Volume: 2,500 shs
• Market Capitalization: N/A
• P/E Ratio: 0.12
• Dividend Yield: 172.60%
• Price Target: N/A
• Consensus Rating: N/A

Sundrug Co.,Ltd. Stock Analysis - MarketRank™

Sundrug Co.,Ltd. scored higher than 44% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Sundrug Co.,Ltd..

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Sundrug Co.,Ltd. is 0.12, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.69.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sundrug Co.,Ltd. is 0.12, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 24.68.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Sundrug Co.,Ltd. has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sundrug Co.,Ltd. has recently decreased by 70.17%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Sundrug Co.,Ltd. pays a meaningful dividend of 1.05%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Sundrug Co.,Ltd. does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Sundrug Co.,Ltd. is 20.98%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: N/A

News Sentiment

Sundrug Co.,Ltd. has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.77 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Sundrug Co.,Ltd. this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sundrug Co.,Ltd. insiders have not sold or bought any company stock.

Percentage Held by Institutions

25.63% of the stock of Sundrug Co.,Ltd. is held by institutions.

Company Calendar

• Today: 6/11/2026
• Next Earnings (Estimated): 8/06/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical Retailers
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SDGCF
• CIK: N/A
• Web: www.sundrug.co.jp
• Phone: (142) 369-6211
• Fax: N/A
• Employees: 6,371
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 0.12
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A